CD19 and Alzheimer disease: In this study, we describe the changes of B cells (CD19+) population due to that it have been described to decrease in patients with psychological alterations as major depression [67], Alzheimer disease [68] or alcohol dependence syndrome [69] which improved after psychological therapy.